Literature DB >> 14766748

Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils.

Shyra J Gardai1, David A Hildeman, Steve K Frankel, Ben B Whitlock, S Courtney Frasch, Niels Borregaard, Philippa Marrack, Donna L Bratton, Peter M Henson.   

Abstract

Although important for apoptosis, the mechanism of Bax regulation is poorly understood. This study demonstrates that phosphorylation of Ser(184) regulates Bax activity. The phosphorylation required phosphatidylinositol 3-kinase/Akt activation and appeared to be mediated by Akt itself. In the serine-phosphorylated form, Bax was detected in the cytoplasm, could not be immunoprecipitated with the activation-specific antibody 6A7, and promoted heterodimerization with Mcl-1, Bcl-x(L), and A1. Apoptotic neutrophils possessed reduced levels of serine-phosphorylated Bax correlating with an increase in activated Bax as well as an increase in the amount of Bax found translocated to the mitochondria. We suggest that Bax is regulated by phosphorylation of Ser(184) in an Akt-dependent manner and that phosphorylation inhibits Bax effects on the mitochondria by maintaining the protein in the cytoplasm, heterodimerized with antiapoptotic Bcl-2 family members.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766748     DOI: 10.1074/jbc.M400063200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  159 in total

Review 1.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Induction of heat shock protein 70 inhibits ischemic renal injury.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon G B Bonegio; Andrea Havasi; Clayton R Hunt; Michael Y Sherman; John H Schwartz; Steven C Borkan
Journal:  Kidney Int       Date:  2011-01-26       Impact factor: 10.612

3.  Akt2: a critical regulator of cardiomyocyte survival and metabolism.

Authors:  Anthony J Muslin
Journal:  Pediatr Cardiol       Date:  2011-01-30       Impact factor: 1.655

4.  PKB/Akt partners with Dab2 in albumin endocytosis.

Authors:  Kelly Koral; Elif Erkan
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-04

5.  Cytosolic Bax: does it require binding proteins to keep its pro-apoptotic activity in check?

Authors:  Sandra Vogel; Nina Raulf; Stephanie Bregenhorn; Martin L Biniossek; Ulrich Maurer; Peter Czabotar; Christoph Borner
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

Review 6.  Mitochondrial regulation of cell cycle and proliferation.

Authors:  Valeria Gabriela Antico Arciuch; María Eugenia Elguero; Juan José Poderoso; María Cecilia Carreras
Journal:  Antioxid Redox Signal       Date:  2012-01-13       Impact factor: 8.401

7.  Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.

Authors:  Yugang Liu; Jian Zheng; Yan Zhang; Zhaotao Wang; Yang Yang; Miaochun Bai; Yiwu Dai
Journal:  Neurochem Res       Date:  2016-07-09       Impact factor: 3.996

8.  The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils.

Authors:  Kelly L Sivertson; Michael C Seeds; David L Long; Kristina K Peachman; David A Bass
Journal:  Cell Immunol       Date:  2007-06-14       Impact factor: 4.868

9.  NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.

Authors:  Wen Zhou; Ye Yang; Jiliang Xia; He Wang; Mohamed E Salama; Wei Xiong; Hongwei Xu; Shashirekha Shetty; Tiehua Chen; Zhaoyang Zeng; Lei Shi; Maurizio Zangari; Rodney Miles; David Bearss; Guido Tricot; Fenghuang Zhan
Journal:  Cancer Cell       Date:  2013-01-14       Impact factor: 31.743

10.  Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation.

Authors:  Teresa G Tessner; Filipe Muhale; Terrence E Riehl; Shrikant Anant; William F Stenson
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.